aTyr Pharma (LIFE) IPO Opens Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
aTyr Pharma, Inc. Announces Pricing of Initial Public Offering
May 6, 2015 8:16 PM EDTSAN DIEGO, May 6, 2015 /PRNewswire/ -- aTyr Pharma, Inc. ("aTyr"), today announced the pricing of its initial public offering of 5,360,000 shares of its common stock at an initial public offering price of $14.00 per share. In addition, aTyr has granted the underwriters a 30-day option to purchase up to an additional 804,000 shares of common stock from aTyr at the initial public offering price, less underwriting discounts and commissions. aTyr's common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading under the ticker symbol "LIFE" on May 7, 2015. Closing of... More
